Characterization of the GSK-3beta protein and methods of use thereof

Details for Australian Patent Application No. 2001292906 (hide)

Owner Chiron Corporation

Inventors Bussiere, Dirksen E.; Martin, Eric; Jansen, Johanna M.; He, Min; Le, Vincent P.; Chin, S. Michael

Agent FB Rice

Pub. Number AU-B-2001292906

PCT Pub. Number WO02/24893

Priority 60/233,538 19.09.00 US

Filing date 19 September 2001

Wipo publication date 2 April 2002

Acceptance publication date 16 August 2007

International Classifications

G01N 23/20 (2006.01) Investigating or analysing materials by the use of wave or particle radiation not covered by group or , e.g. X-rays, neutrons - by using diffraction of the radiation, e.g. for investigating crystal structure

C12N 9/12 (2006.01) Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G06F 17/30 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific functions - Information retrieval

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

16 August 2007 Application Accepted

  Published as AU-B-2001292906

13 December 2007 Standard Patent Sealed

27 November 2008 Alteration of Name

  The name of the patentee has been altered to Novartis Vaccines and Diagnostics, Inc. 2002

15 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001292907-5-chloro-3-(4-methanesulfonylphenyl)-6' -methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis

2001292905